Epigenetic regulation of lymphoid cell development and function

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Inflammatory diseases such as multiple sclerosis, inflammatory bowel disease and asthma are caused by unregulated white blood cells called CD4 T cells. Why certain people develop hyperactive CD4 T cells is not clear but a understanding how CD4 T cells are regulated will help inform future therapies. Our research focuses on one enzyme called G9a that modifies proteins that control immune cell function. Our goal is to define the role of this enzyme in inflammation to aid in drug development.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2018

Funding Scheme: Project Grants

Funding Amount: $631,950.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Cellular Immunology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

T cell response | epigenetics | inflammatory bowel disease (IBD) | innate immunity | lung inflammation